{
    "title": "A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics",
    "pmid": "26745506",
    "pmcid": "PMC4706412",
    "study_parameters": [
        {
            "Study Parameters ID": 1447682702,
            "Variant Annotation ID": 1447682700,
            "Study Type": "cohort, retrospective",
            "Study Cases": 255.0,
            "Study Controls": null,
            "Characteristics": "NCT01318057; CYP4F3 *3 partial reg. coeff. 0.560 (SE 0.2274), adj R sq0.0.673",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.115,
            "Allele Of Frequency In Cases": "*3",
            "Frequency In Controls": 0.885,
            "Allele Of Frequency In Controls": "*1",
            "P Value": "= 0.014",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1447682700"
        },
        {
            "Study Parameters ID": 1447682655,
            "Variant Annotation ID": 1447682605,
            "Study Type": "cohort, retrospective",
            "Study Cases": 255.0,
            "Study Controls": null,
            "Characteristics": "NCT01318057; CYP2C9 *2 partial reg. coeff. -0.245 (SE 0.1654), adj R sq0.613",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.09,
            "Allele Of Frequency In Cases": "*2",
            "Frequency In Controls": 0.83,
            "Allele Of Frequency In Controls": "*1",
            "P Value": "= 0.014",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1447682605"
        },
        {
            "Study Parameters ID": 1447682664,
            "Variant Annotation ID": 1447682605,
            "Study Type": "cohort, retrospective",
            "Study Cases": 255.0,
            "Study Controls": null,
            "Characteristics": "Study Cohort: NCT01318057; CYP2C9 *3 partial reg. coeff. -0.544 (SE 0.2224), adj R sq 0.625",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.05,
            "Allele Of Frequency In Cases": "*3",
            "Frequency In Controls": 0.83,
            "Allele Of Frequency In Controls": "*1",
            "P Value": "= 0.015",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1447682605"
        },
        {
            "Study Parameters ID": 1447682687,
            "Variant Annotation ID": 1447682605,
            "Study Type": "cohort, retrospective",
            "Study Cases": 255.0,
            "Study Controls": null,
            "Characteristics": "NCT01318057; CYP2C9 *8 partial reg. coeff. -1.00 (SE 0.6014), adj R sq 0.638",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.006,
            "Allele Of Frequency In Cases": "*8",
            "Frequency In Controls": 0.83,
            "Allele Of Frequency In Controls": "*1",
            "P Value": "= 0.098",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1447682605"
        },
        {
            "Study Parameters ID": 1447682693,
            "Variant Annotation ID": 1447682688,
            "Study Type": "cohort, retrospective",
            "Study Cases": 255.0,
            "Study Controls": null,
            "Characteristics": "NCT01318057; VKORC1 rs9923231 AA partial reg. coeff. -0.896 (SE 0.2169), adj R sq .0.641",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.0001",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1447682688"
        },
        {
            "Study Parameters ID": 1447682695,
            "Variant Annotation ID": 1447682688,
            "Study Type": "cohort, retrospective",
            "Study Cases": 255.0,
            "Study Controls": null,
            "Characteristics": "NCT01318057; VKORC1 rs9923231 AG partial reg. coeff. -0.379 (SE 0.1391), adj R sq .0.659",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": null,
            "Allele Of Frequency In Cases": null,
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "= 0.007",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Unknown",
            "Variant Annotation ID_norm": "1447682688"
        },
        {
            "Study Parameters ID": 1447682724,
            "Variant Annotation ID": 1447682722,
            "Study Type": "cohort, retrospective",
            "Study Cases": 255.0,
            "Study Controls": null,
            "Characteristics": "NCT01318057; NQO1 rs1800566 A allele partial reg. coeff. 0.346 (SE 0.2246), adj R sq .0.689",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.098,
            "Allele Of Frequency In Cases": "A",
            "Frequency In Controls": 0.902,
            "Allele Of Frequency In Controls": "G",
            "P Value": "= 0.125",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "Latino",
            "Variant Annotation ID_norm": "1447682722"
        }
    ],
    "var_drug_ann": [
        {
            "Variant Annotation ID": 1447682700,
            "Variant/Haplotypes": "CYP4F2*1, CYP4F2*3",
            "Gene": "CYP4F2",
            "Drug(s)": "warfarin",
            "PMID": 26745506,
            "Phenotype Category": "Dosage",
            "Significance": "yes",
            "Notes": "The authors aimed to develop an admixture-adjusted (genetic ancestry) PGx dosing algorithm for warfarin in Caribbean Hispanics from Puerto Rico. [Algorithm R sq.=0.70, MAE = 0.72 mg/day]. When externally validated with 55 individuals from an independent cohort the novel algorithm predicted 58% of the warfarin dose variance [MAE = 0.89 mg/day, 24% mean bias]. Please note: the derivation cohort was 99% male.",
            "Sentence": "CYP4F2 *3 is associated with increased dose of warfarin as compared to CYP4F2 *1.",
            "Alleles": "*3",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "dose of",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "26745506",
            "Variant Annotation ID_norm": "1447682700"
        },
        {
            "Variant Annotation ID": 1447682605,
            "Variant/Haplotypes": "CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8",
            "Gene": "CYP2C9",
            "Drug(s)": "warfarin",
            "PMID": 26745506,
            "Phenotype Category": "Dosage",
            "Significance": "yes",
            "Notes": "The authors aimed to develop an admixture-adjusted (genetic ancestry) PGx dosing algorithm for warfarin in Caribbean Hispanics from Puerto Rico. [Algorithm R sq.=0.70, MAE = 0.72 mg/day]. When externally validated with 55 individuals from an independent cohort the novel algorithm predicted 58% of the warfarin dose variance [MAE = 0.89 mg/day, 24% mean bias]. Please note: the derivation cohort was 99% male and  \"variables were included in final lin. reg model if p<0.05 or if association with daily warfarin dose was marginally significant 0.05 = p = 0.20 with strong biological plausibility\".",
            "Sentence": "CYP2C9 *2 + *3 + *8 are associated with decreased dose of warfarin as compared to CYP2C9 *1.",
            "Alleles": "*2 + *3 + *8",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "dose of",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "*1",
            "Comparison Metabolizer types": null,
            "PMID_norm": "26745506",
            "Variant Annotation ID_norm": "1447682605"
        },
        {
            "Variant Annotation ID": 1447682688,
            "Variant/Haplotypes": "rs9923231",
            "Gene": "VKORC1",
            "Drug(s)": "warfarin",
            "PMID": 26745506,
            "Phenotype Category": "Dosage",
            "Significance": "yes",
            "Notes": "The authors aimed to develop an admixture-adjusted (genetic ancestry) PGx dosing algorithm for warfarin in Caribbean Hispanics from Puerto Rico. [Algorithm R sq.=0.70, MAE = 0.72 mg/day]. When externally validated with 55 individuals from an independent cohort the novel algorithm predicted 58% of the warfarin dose variance [MAE = 0.89 mg/day, 24% mean bias]. Please note: the derivation cohort was 99% male.",
            "Sentence": "Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.",
            "Alleles": "CT + TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "dose of",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "CC",
            "Comparison Metabolizer types": null,
            "PMID_norm": "26745506",
            "Variant Annotation ID_norm": "1447682688"
        },
        {
            "Variant Annotation ID": 1447682722,
            "Variant/Haplotypes": "rs1800566",
            "Gene": "NQO1",
            "Drug(s)": "warfarin",
            "PMID": 26745506,
            "Phenotype Category": "Dosage",
            "Significance": "yes",
            "Notes": "The authors aimed to develop an admixture-adjusted (genetic ancestry) PGx dosing algorithm for warfarin in Caribbean Hispanics from Puerto Rico. [Algorithm R sq.=0.70, MAE = 0.72 mg/day]. When externally validated with 55 individuals from an independent cohort the novel algorithm predicted 58% of the warfarin dose variance [MAE = 0.89 mg/day, 24% mean bias]. Please note: 1) the derivation cohort was 99% male 2) alleles have been complemented to the + chromosomal strand and 3) \"variables were included in final lin. reg model if p<0.05 or if association with daily warfarin dose was marginally significant 0.05 = p = 0.20 with strong biological plausability\".",
            "Sentence": "Genotypes AA + AG are associated with increased dose of warfarin as compared to genotype GG.",
            "Alleles": "AA + AG",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Are",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "increased",
            "PD/PK terms": "dose of",
            "Multiple drugs And/or": null,
            "Population types": null,
            "Population Phenotypes or diseases": null,
            "Multiple phenotypes or diseases And/or": null,
            "Comparison Allele(s) or Genotype(s)": "GG",
            "Comparison Metabolizer types": null,
            "PMID_norm": "26745506",
            "Variant Annotation ID_norm": "1447682722"
        }
    ],
    "var_pheno_ann": [],
    "var_fa_ann": []
}